Media Coverage (Proteomics)
Proteomics
-
- All Categories
- Brain Health
- Cancers
- Cell Dynamics
- Computational Biology
- COVID-19
- Disease
- Environment
- Experimental
- Healthspan
- Healthy Aging
- Immune System
- Infectious Disease
- Microbiome
- Nobel Prize
- Pregnancy Health
- Proteomics
- Scientific Wellness
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
How a Global Effort to Explore the ‘Dark Proteome’ Is Upending Our Understanding of Human Disease
An international study co-authored by ISB researchers and published in the journal Nature identified more than 1,700 previously unknown protein-like molecules hidden within the human genome. The story explores how these newly discovered “peptideins” could reshape scientists’ understanding of cancer, immunotherapy, and human disease.
The Human Genome Encodes for a New Category of Molecule
The Economist highlighted an international study co-authored by ISB researchers that identified a new class of protein-like molecules called “peptideins.” The feature explores how the discovery expands scientists’ understanding of the human genome and could reshape future research into cancer, immunotherapy, and human disease.
NIH Researchers Discover Novel Class of Anti-Malaria Antibodies
Kristian Swearengen helped develop a novel class of antibodies that binds to a previously untargeted portion of the malaria parasite – work that could lead to new prevention methods.
Nobel Laureate Dr. Mary Brunkow speaks at a press conference held at ISB on October 7, 2025. (Photo by Alex Garland for ISB)
ISB’s 2025 Nobel Prize Coverage
ISB’s Dr. Mary Brunkow received the 2025 Nobel Prize in Physiology or Medicine for transformative discoveries in immune tolerance.
Visit our Nobel Prize hub page for stories, photos, reactions celebrating this historic achievement, and more.